Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries (Q34213437)

31 July 2017

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries (English)

1 reference

31 July 2017

anti-retroviral agent

0 references

0 references

11

Ard van Sighem

1 reference

31 July 2017

13

Caroline Sabin

0 references

Dominique Costagliola

23

Dominique Costagliola

0 references

Jonathan Sterne

Jonathan Sterne

6

0 references

Hansjakob Furrer

4

Hansjakob Furrer

1 reference

ORCID Public Data File 2021

31 July 2017

0 references

0 references

1 reference

Andrew N Phillips

9

Andrew Phillips

1 reference

31 July 2017

15

Amy Justice

1 reference

31 July 2017

Julia del Amo

1

1 reference

31 July 2017

Santiago Moreno

2

1 reference

31 July 2017

Heiner C Bucher

3

1 reference

31 July 2017

Roger Logan

5

1 reference

31 July 2017

Santiago Pérez-Hoyos

7

1 reference

31 July 2017

Inma Jarrín

8

1 reference

31 July 2017

Sara Lodi

10

1 reference

31 July 2017

Wolf de Wolf

12

1 reference

31 July 2017

Loveleen Bansi

14

1 reference

31 July 2017

Joseph Goulet

16

1 reference

31 July 2017

José M Miró

17

1 reference

31 July 2017

Elena Ferrer

18

1 reference

31 July 2017

Laurence Meyer

19

1 reference

31 July 2017

Rémonie Seng

20

1 reference

31 July 2017

Giota Toulomi

21

1 reference

31 July 2017

Panagiotis Gargalianos

22

1 reference

31 July 2017

Sophie Abgrall

24

1 reference

31 July 2017

Miguel A Hernán

25

1 reference

31 July 2017

HIV-CAUSAL Collaboration

26

1 reference

31 July 2017

language of work or name

English

0 references

publication date

28 March 2012

1 reference

Clinical Infectious Diseases

31 July 2017

1 reference

31 July 2017

54

1 reference

31 July 2017

9

1 reference

31 July 2017

1364-1372

1 reference

Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Changing concepts of "latent tuberculosis infection" in patients living with HIV infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Early versus standard antiretroviral therapy for HIV-infected adults in Haiti

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

A structural approach to selection bias

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Marginal structural models and causal inference in epidemiology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3404691

Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

5 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS203

Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS203

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS203

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS203

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS203

Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS203

Effectiveness of Antiretroviral Treatment in a South African Program A Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS203

Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS203

HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22460971

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

HIV and premature aging: A field still in its infancy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22460971

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/CID/CIS203

1 reference

31 July 2017

1 reference

31 July 2017

1 reference